Following the recent district court decision to remand to the Department of Health and Human Services the question of how to repay 340B hospitals for funds unlawfully withheld for five years, AHA today asked to meet with the responsible HHS team to discuss its forthcoming remedial proposal. The letter also offered five guiding principles in the hope of expediting this administrative process and avoiding further legal challenges. 

Specifically, the letter calls for HHS to: 

•    Repay each 340B hospital the full amount that was unlawfully withheld between January 2018 and September 2022;
•    Repay each 340B hospital promptly;
•    Not impose a prospective remedy; 
•    Pay hospitals interest on its underpayments until they are fully repaid; and 
•    Not recoup funds from the hospital field to achieve budget neutrality. 

“As the AHA has stated before, we are willing to work with HHS to assure a fair and equitable resolution of these issues, which have already taken far too long to resolve, at great cost to the entire hospital field,” the AHA letter states. “Working together, HHS and the AHA can develop a fair and administrable remedy that avoids further legal or administrative delay.”

View the AHA letter for more details on each of these principles. 

Headline
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…